Trials / Completed
CompletedNCT02495402
Substance Abuse Treatment to HIV Care (SAT2HIV): The Motivational Interviewing-based Brief Intervention Experiment
Substance Abuse Treatment to HIV Care (SAT2HIV): The Motivational Interviewing-based Brief Intervention (MIBI) Experiment
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 827 (actual)
- Sponsor
- RTI International · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Accepted
Summary
To test the effectiveness of a single 20-30 minute motivational interviewing-based brief intervention for substance use within HIV/AIDS settings.
Detailed description
The Substance Abuse Treatment to HIV care (SAT2HIV) project, a Type 2 Effectiveness-Implementation Hybrid Trial, seeks to address this gap in services by providing new knowledge regarding the effectiveness of brief intervention (BI) for substance use within community-based HIV/AIDS service settings, as well as new knowledge regarding how to address the well-documented underutilization of evidence-based practices in real-world settings. The specific aims of this project are: Aim 1: To experimentally test the effectiveness of a motivational interviewing-based BI for substance use within community-based HIV/AIDS service organizations, relative to usual care (UC). Aim 2: To experimentally test the effectiveness of adding an organizational-level implementation intervention called Implementation \& Sustainment Facilitation (ISF) to enhance the effectiveness of the implementation strategy currently used by SAMHSA-funded Addiction Technology Treatment Centers (ATTCs; i.e., online introductory training, 2-day training workshop, ongoing feedback and coaching).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Motivational Interviewing | Participants assigned to the experimental condition receive a single 20-30 minute motivational interviewing-based brief intervention for substance use. |
Timeline
- Start date
- 2015-07-08
- Primary completion
- 2017-12-28
- Completion
- 2018-03-25
- First posted
- 2015-07-13
- Last updated
- 2018-05-09
Locations
39 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02495402. Inclusion in this directory is not an endorsement.